Company: NUTR
Filing Date: 2025-03-25
Form Type: CORRESP
Source: 0001641172-25-000449
Chunk: 250

Company: NUSATRIP Inc
Filing Date: 2025-03-25
Form: CORRESP
Chunk 250
---
 receive any proceeds from the sale of
Common Stock by the Selling Stockholders. In addition, the underwriters will not receive any compensation from the sale of the Common
Stock by the Selling Stockholders. The Selling Stockholders will receive all of the net proceeds from the sales of Common Stock offered
by it under this prospectus.

The Selling Stockholders will pay any underwriting
discounts and commissions and expenses incurred by them for brokerage, accounting, tax or legal services or any other expenses incurred
by them in disposing of the shares. We will bear all other costs, fees and expenses incurred in effecting the registration of the shares
covered by this prospectus, including, without limitation, all registration and filing fees and fees and expenses of our counsel and
our accountants.

| Alt-2 |

<div align='center'>[Alternate Page for Resale Prospectus]

SELLING STOCKHOLDERS</div>

The shares of Common Stock being offered by the Selling
Stockholders are those held by the Selling Stockholders or issuable to the Selling Stockholders upon the exercise of certain convertible
notes, that are convertible into shares of Common Stock, held by the Selling Stockholders or automatic conversion of certain convertible
notes into shares of Common Stock held by the Selling Stockholders. On October 18, 2024, we entered into a securities purchase agreement
with the Selling Stockholders. Pursuant to securities purchase agreement, on October 18, 2024, we issued convertible notes (the “Convertible
Notes”) to the Selling Stockholders with an aggregate principal amount of $1,600,002 (the “Convertible Notes Offering”).
Pursuant to the amendments to the securities purchase agreement for Convertible Notes dated November 13, 2024, entered by the Company
and the investors, the Convertible Notes shall automatically convert into shares of our common stock upon the effectiveness of the registration
statement at the conversion price of $1.50 per share. We are obligated to pay interest to the Selling Stockholders on the outstanding
principal amount at the rate of 6.0% per annum. The Convertible Notes and the interests shall be converted into shares of common stock
of the Company at a conversion price of $1.50 per share by the six months anniversary of the issuance date or the consummation of our
IPO, whichever earlier. The Convertible Notes were converted into an aggregate of 1,066,668 shares of Common Stock and issued to the investors, and the three private